The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
Open accessAbstract
Necrosis can induce profound inflammation or be clinically silent. However, the mechanisms underlying such tissue specificity are unknown. Interleukin-1α (IL-1α) is a key danger signal released upon necrosis that exerts effects on both innate and adaptive immunity and is considered to be constitutively active. In contrast, we have shown that necrosis-induced IL-1α activity is tightly controlled in a cell type-specific manner. Most cell types examined expressed a cytosolic IL-1 receptor 2 (IL-1R2) whose binding to pro-IL-1α inhibited its cytokine activity. In cell types exhibiting a silent necrotic phenotype, IL-1R2 remained associated with pro-IL-1α. Cell types possessing inflammatory necrotic phenotypes either lacked IL-1R2 or had activated caspase-1 before necrosis, which degraded and dissociated IL-1R2 from pro-IL-1α. Full IL-1α activity required cleavage by calpain after necrosis, which increased its affinity for IL-1 receptor 1. Thus, we report a cell type-dependent process that fundamentally governs IL-1α activity postnecrosis and the mechanism allowing conditional release of this blockade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, necrotic VSMCs potently drive inflammation via IL1α due to a lack of IL-1R2 that normally binds and inhibits IL-1α 133,189 .”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 2×
“Indeed, increased IL-1 activity is a hallmark of many chronic inflammatory conditions, including rheumatoid arthritis, gout, diabetes, atherosclerosis, and psoriasis (Dinarello, 1996, 2009; Duewell et al., 2010; Rajamäki et al., 2010).”
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559
Flagged first, then by citations
Cited by
Sorted by citations
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
“Because IL-1R2 is expressed by a limited set of cells, this would represent a further mechanism of negative control of IL-1a by IL-1R2 during necrosis, restricted to specific cell types (Zheng et al., 2013).”
Vascular smooth muscle cells in atherosclerosis
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0227-9 · Cited by 1,099
Self-citationPyroptosis versus necroptosis: similarities, differences, and crosstalk
Frank, D., & Vince, J. E. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0212-6 · Cited by 1,062
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Mantovani, A., Dinarello, C. A., Molgora, M., & Garlanda, C. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.012 · Cited by 1,046
Walsh, J. G., Muruve, D. A., & Power, C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3638 · Cited by 637
COVID-19 infection: an overview on cytokine storm and related interventions
Montazersaheb, S., Khatibi, S. M. H., Hejazi, M. S., Tarhriz, V., Farjami, A., Sorbeni, F. G., Farahzadi, R., & Ghasemnejad, T. (2022) · Virology Journal · doi:10.1186/s12985-022-01814-1 · Cited by 657
Interleukin 1α and the inflammatory process
Di Paolo, N. C., & Shayakhmetov, D. M. (2016) · Nature Immunology · doi:10.1038/ni.3503 · Cited by 568
Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
Afonina, I. S., Müller, C., Martin, S. J., & Beyaert, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.003 · Cited by 483
Post-stroke inflammation—target or tool for therapy?
Lambertsen, K. L., Finsen, B. R., & Clausen, B. H. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1930-z · Cited by 477
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Bertheloot, D., & Latz, E. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.34 · Cited by 455
Palomo, J., Dietrich, D., Martin, P., Palmer, G., & Gabay, C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.017 · Cited by 458
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2017) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 399
Inflammasome signaling and regulation of interleukin-1 family cytokines
Chan, A. H., & Schroder, K. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190314 · Cited by 388
The IL-1 family of cytokines and receptors in rheumatic diseases
Dinarello, C. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0277-8 · Cited by 387
Cavalli, G., Colafrancesco, S., Emmi, G., Imazio, M., Lopalco, G., Maggio, M. C., Sota, J., & Dinarello, C. A. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102763 · Cited by 370
Pathogenesis of acute stroke and the role of inflammasomes
Fann, D. Y., Lee, S.-Y., Manzanero, S., Chunduri, P., Sobey, C. G., & Arumugam, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.004 · Cited by 334
Function and regulation of IL ‐1α in inflammatory diseases and cancer
Malik, A., & Kanneganti, T. (2017) · Immunological Reviews · doi:10.1111/imr.12615 · Cited by 331
Gardner, S. E., Humphry, M., Bennett, M. R., & Clarke, M. C. H. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305896 · Cited by 285
Self-citationDuffy, D., Rouilly, V., Libri, V., Hasan, M., Beitz, B., David, M., Urrutia, A., Bisiaux, A., LaBrie, S. T., Dubois, A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.002 · Cited by 242
The interleukin-1 receptor family
Boraschi, D., & Tagliabue, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.023 · Cited by 255
The role IL-1 in tumor-mediated angiogenesis
Voronov, E., Carmi, Y., & Apte, R. N. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00114 · Cited by 233
Burzynski, L. C., Humphry, M., Pyrillou, K., Wiggins, K. A., Chan, J. N. E., Figg, N. L., Kitt, L., Summers, C., Tatham, K. C., Martin, P. B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.003 · Cited by 222
Self-citationKim, B., Lee, Y. M., Kim, E., Kwak, A., Ryoo, S., Bae, S. H., Azam, T., Kim, S., & Dinarello, C. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00391 · Cited by 231
Processes of Sterile Inflammation
Shen, H., Kreisel, D., & Goldstein, D. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301539 · Cited by 214
Martin, S. J. (2016) · FEBS Journal · doi:10.1111/febs.13775 · Cited by 188
Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
Pyrillou, K., Burzynski, L. C., & Clarke, M. C. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613170 · Cited by 202
Self-citationRider, P., Voronov, E., Dinarello, C. A., Apte, R. N., & Cohen, I. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601342 · Cited by 186
Yazdi, A. S., & Ghoreschi, K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_2 · Cited by 174
Rider, P., Carmi, Y., Voronov, E., & Apte, R. N. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.005 · Cited by 155
Release of Interleukin-1α or Interleukin-1β Depends on Mechanism of Cell Death
England, H., Summersgill, H. R., Edye, M. E., Rothwell, N. J., & Brough, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557561 · Cited by 151
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
Boyapati, R. K., Rossi, A. G., Satsangi, J., & Ho, G. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.14 · Cited by 150
NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen
Nordlander, S., Pott, J., & Maloy, K. J. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.95 · Cited by 147
Unique versus redundant functions of IL-1α and IL-1β in the tumor microenvironment
Voronov, E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00177 · Cited by 149
NLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 144
Carty, M., Kearney, J., Shanahan, K. A., Hams, E., Sugisawa, R., Connolly, D. J., Doran, C. G., Muñoz‐Wolf, N., Gürtler, C., Fitzgerald, K. A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.005 · Cited by 147
Gasdermin D mediates the maturation and release of IL-1α downstream of inflammasomes
Tsuchiya, K., Hosojima, S., Hara, H., Kushiyama, H., Mahib, M. R., Kinoshita, T., & Suda, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108887 · Cited by 137
Caffrey, A. K., Lehmann, M. M., Zickovich, J. M., Espinosa, V., Shepardson, K. M., Watschke, C. P., Hilmer, K. M., Thammahong, A., Barker, B. M., Rivera, A., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004625 · Cited by 132
Sobowale, O. A., Parry‐Jones, A., Smith, C. J., Tyrrell, P. J., Rothwell, N. J., & Allan, S. M. (2016) · Stroke · doi:10.1161/strokeaha.115.010001 · Cited by 131
IL-1α Signaling Initiates the Inflammatory Response to Virulent Legionella pneumophila In Vivo
Barry, K. C., Fontana, M. F., Portman, J. L., Dugan, A. S., & Vance, R. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300100 · Cited by 128
IL-1 family cytokines in inflammation and immunity
Garlanda, C., Ceglie, I. D., & Jaillon, S. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01358-8 · Cited by 153
IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer
Voronov, E., & Apte, R. N. (2015) · Cancer Microenvironment · doi:10.1007/s12307-015-0177-7 · Cited by 128
Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
Wu, X., Dong, L., Lin, X., & Li, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01728 · Cited by 122
Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies
Montgomery, S., Mall, M. A., Kicic, A., & Stick, S. M. (2016) · European Respiratory Journal · doi:10.1183/13993003.00903-2016 · Cited by 130
Kim, J., Gee, H. Y., & Lee, M. G. (2018) · Journal of Cell Science · doi:10.1242/jcs.213686 · Cited by 131
Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Cinier, J., Hubert, M., Besson, L., Roio, A. D., Rodriguez, C., Lombardi, V., Caux, C., & Ménétrier‐Caux, C. (2021) · Cancers · doi:10.3390/cancers13081850 · Cited by 125
Tuning inflammation and immunity by the negative regulators IL ‐1R2 and IL ‐1R8
Molgora, M., Supino, D., Mantovani, A., & Garlanda, C. (2017) · Immunological Reviews · doi:10.1111/imr.12609 · Cited by 116
Scott, I. C., Majithiya, J. B., Sandén, C., Thornton, P., Sanders, P. N., Moore, T., Guscott, M. A., Corkill, D. J., Erjefalt, J. S., & Cohen, E. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21589-2 · Cited by 115
Bastien, D., & Lacroix, S. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.006 · Cited by 119
Wiggins, K. A., Parry, A., Cassidy, L. D., Humphry, M., Webster, S. J., GOODALL, J. C., Narita, M., & Clarke, M. C. H. (2019) · Aging Cell · doi:10.1111/acel.12946 · Cited by 104
Self-citationNegative regulatory receptors of the IL-1 family
Garlanda, C., Riva, F., Bonavita, E., & Mantovani, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.019 · Cited by 102
Zhang, C., Feng, J., Du, J., Zhuo, Z., Yang, S., Zhang, W., Wang, W., Zhang, S., Iwakura, Y., Meng, G., et al. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.22 · Cited by 99
The three cytokines IL-1β, IL-18, and IL-1α share related but distinct secretory routes
Tapia, V. S., Daniels, M. J. D., Palazón‐Riquelme, P., Dewhurst, M. R., Luheshi, N., Rivers‐Auty, J., Green, J., Redondo‐Castro, E., Kaldis, P., López‐Castejón, G., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008009 · Cited by 94
Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction
WEIGT, S. S., Palchevskiy, V., & Belperio, J. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93537 · Cited by 93
Galozzi, P., Bindoli, S., Doria, A., & Sfriso, P. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102785 · Cited by 91
Mar, A.-C., Chu, C.-H., Lee, H.-J., Chien, C.-W., Cheng, J., Yang, S.-H., Jiang, J., & Lee, T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.644823 · Cited by 90
Redefining the ancestral origins of the interleukin-1 superfamily
Rivers‐Auty, J., Daniels, M. J. D., Colliver, I., Robertson, D. L., & Brough, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03362-1 · Cited by 88
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
Li, Y., & Jiang, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128358 · Cited by 92
Regulatory Role of IL-1R8 in Immunity and Disease
Molgora, M., Barajon, I., Mantovani, A., & Garlanda, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00149 · Cited by 79
Qudus, M. S., Tian, M., Sirajuddin, S., Liu, S., Afaq, U., Wali, M., Liu, J., Pan, P., Luo, Z., Zhang, Q., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28751 · Cited by 84
The Immune System in the Pathogenesis of Ovarian Cancer
Charbonneau, B., Goode, E. L., Kalli, K. R., Knutson, K. L., & DeRycke, M. S. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006813 · Cited by 75
Molecular determinants of sterile inflammation
Kono, H., Onda, A., & Yanagida, T. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.004 · Cited by 77
Scarpa, M., Kessler, S. P., Sadler, T. M., West, G. A., Homer, C. R., McDonald, C., de la Motte, C., Fiocchi, C., & Stylianou, E. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.018 · Cited by 78
Critical role of calpain in inflammation
Ji, J., Su, L., & Liu, Z. (2016) · Biomedical Reports · doi:10.3892/br.2016.785 · Cited by 75
Decoys and Regulatory “Receptors” of the IL-1/Toll-Like Receptor Superfamily
Garlanda, C., Riva, F., Bonavita, E., Gentile, S., & Mantovani, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00180 · Cited by 72
Emerging Concepts about NAIP/NLRC4 Inflammasomes
Lage, S. L., Longo, C., Branco, L. M., Boccia, T., Buzzo, C. D. L., & Bortoluci, K. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00309 · Cited by 74
Healy, L. L., Cronin, J., & Sheldon, I. M. (2014) · Scientific Reports · doi:10.1038/srep07060 · Cited by 72
Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures
Félix, J., & Savvides, S. N. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.134 · Cited by 70
Supino, D., Minute, L., Mariancini, A., Riva, F., Magrini, E. I., & Garlanda, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.804641 · Cited by 70
Ren, X., Gelinas, A. D., von Carlowitz, I., Janjić, N., & Pyle, A. M. (2017) · Nature Communications · doi:10.1038/s41467-017-00864-2 · Cited by 66
Zhang, L., Qiang, J., Yang, X., Wang, D., Rehman, A. U., He, X., Chen, W., Sheng, D., Zhou, L., Jiang, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201901728 · Cited by 66
Interleukin 1α Is Critical for Resistance against Highly Virulent Aspergillus fumigatus Isolates
Caffrey-Carr, A. K., Kowalski, C. H., Beattie, S. R., Blaseg, N. A., Upshaw, C. R., Thammahong, A., Lust, H. E., Tang, Y., Hohl, T. M., Cramer, R. A., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00661-17 · Cited by 62
The IL-1 cytokine family as custodians of barrier immunity
Matarazzo, L., Hernandez-Santana, Y., Walsh, P. T., & Fallon, P. G. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155890 · Cited by 67
The role of inflammation and interleukin-1 in acute cerebrovascular disease
Brough, D., & Galea, J. P. (2013) · Journal of Inflammation Research · doi:10.2147/jir.s35629 · Cited by 63
Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10
Charbonneau, B., Block, M. S., Bamlet, W. R., Vierkant, R. A., Kalli, K. R., Fogarty, Z. C., Rider, D. N., Sellers, T. A., Tworoger, S. S., Poole, E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1051 · Cited by 62
Iznardo, H., & Puig, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169479 · Cited by 66
Pyroptotic death storms and cytopenia
Croker, B. A., O’Donnell, J. A., & Gerlic, M. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.002 · Cited by 60
IL-1α Processing, Signaling and Its Role in Cancer Progression
Chiu, J. W., Hanafi, Z. B., Chew, L. C. Y., Mei, Y., & Liu, H. (2021) · Cells · doi:10.3390/cells10010092 · Cited by 58
Inflammatory signaling on cytochrome P450-mediated drug metabolism in hepatocytes
Wang, X., Rao, J., Tan, Z., Xun, T., Zhao, J., & Xixiao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043836 · Cited by 62
Edye, M. E., López‐Castejón, G., Allan, S. M., & Brough, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478941 · Cited by 59
Bastien, D., Bellver‐Landete, V., Lessard, M., Vallières, N., Champagne, M.-E., Takashima, A., Tremblay, M., Doyon, Y., & Lacroix, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0498-15.2015 · Cited by 65
The IL-1 family in tumorigenesis and antitumor immunity
Sun, R., Gao, D. S., Shoush, J., & Lu, B. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.002 · Cited by 58
Interleukin-1α and brain inflammation
Brough, D., & Denes, A. (2015) · IUBMB Life · doi:10.1002/iub.1377 · Cited by 54
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation
Bonecchi, R., Garlanda, C., Mantovani, A., & Riva, F. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.023 · Cited by 54
Immune-mediated mechanisms of atherosclerosis and implications for the clinic
Nus, M., & Mallat, Z. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1195686 · Cited by 57
Unconventional Pathways of Secretion Contribute to Inflammation
Daniels, M. J. D., & Brough, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010102 · Cited by 50
IL-36 family cytokines in protective versus destructive inflammation
Han, Y., Huard, A., Mora, J., da Silva, P., Brüne, B., & Weigert, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109773 · Cited by 50
Paolo, N. C. D., Baldwin, L. K., Irons, E. E., Papayannopoulou, T., Tomlinson, S., & Shayakhmetov, D. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004035 · Cited by 48
The IL-1 family in fish: Swimming through the muddy waters of inflammasome evolution
Ogryzko, N. V., Renshaw, S. A., & Wilson, H. L. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.03.008 · Cited by 47
Regulation of IL-1 signaling by the decoy receptor IL-1R2
Schlüter, T., Schelmbauer, C., Karram, K., & Mufazalov, I. A. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1684-z · Cited by 50
IL-1/IL-1R Signaling in Head and Neck Cancer
Niklander, S. E., Murdoch, C., & Hunter, K. D. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.722676 · Cited by 43
Multiomic‐based immune response profiling in migraine, vestibular migraine and Meniere's disease
Cruz‐Granados, P., Frejo, L., Perez‐Carpena, P., Amor‐Dorado, J. C., Domínguez‐Durán, E., Fernández-Nava, M. J., Caletrío, Á. B., Haro‐Hernandez, E., Martinez‐Martinez, M., & Lopez-Escamez, J. A. (2024) · Immunology · doi:10.1111/imm.13863 · Cited by 44
Tian, X., Sun, H., Casbon, A.-J., Lim, E., Francis, K. P., Hellman, J., & Prakash, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01337 · Cited by 38
Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
Vecchié, A., Buono, M. G. D., Chiabrando, J. G., Dentali, F., Abbate, A., & Bonaventura, A. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01589-x · Cited by 43
ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface
Uchikawa, S., Yoda, M., Tohmonda, T., Kanaji, A., Matsumoto, M., Toyama, Y., & Horiuchi, K. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.032 · Cited by 36
Interleukin-1 in Coronary Artery Disease
Oikonomou, E. K., Tsaplaris, P., Anastasiou, A., Xenou, M., Lampsas, S., Siasos, G., Pantelidis, P., Theofilis, P., Tsatsaragkou, A., Κατσαρού, Ο., et al. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221017144734 · Cited by 35
Kandel-Kfir, M., Almog, T., Shaish, A., Shlomai, G., Anafi, L., Avivi, C., Barshack, I., Grosskopf, I., Harats, D., & Kamari, Y. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.012 · Cited by 34
Cutting Edge: IL-1α and Not IL-1β Drives IL-1R1–Dependent Neonatal Murine Sepsis Lethality
Benjamin, J. T., Moore, D. J., Bennett, C., van der Meer, R., Royce, A., Loveland, R., & Wynn, J. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1801089 · Cited by 34
An approach to local immunotoxicity induced by adjuvanted vaccines
Batista-Duharte, A., Portuondo, D. L., Carlos, I. Z., & Pérez, Ó. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.07.025 · Cited by 33
Li, S., Zeng, X., Zhou, X., Wang, H., Jo, E., Robinson, S. R., Xu, A., & Ye, J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.021 · Cited by 32
Human S100A7 Induces Mature Interleukin1α Expression by RAGE-p38 MAPK-Calpain1 Pathway in Psoriasis
Lei, H., Li, X., Jing, B., Xu, H., & Wu, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169788 · Cited by 32
Metadata
- Authors
- Zheng, Y., Humphry, M., Maguire, J. J., Bennett, M. R., & Clarke, M. C. H.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Clarke, Murray C.H.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 38
- Issue
- 2
- Pages
- 285-295
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC3659285
- OpenAlex
- W2038182824
- Cited by
- 205
- References
- 54
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 15 · 2023: 11 · 2022: 18 · 2021: 15 · 2020: 6 · 2019: 14 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 20 · 2014: 18 · 2013: 22
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Immunity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- National Institute for Health and Care Research
- British Heart Foundation (RG/08/009/25841, PG/06/024/20354, FS/13/3/30038, RG04/001, FS/09/005/26845)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- interleukin-1 alpha, interleukin-1 receptor 2, sterile inflammation, necrosis, caspase-1, calpain, IL-1 receptor 1, damage-associated molecular patterns
- MeSH terms
- Animals, Calpain, Cell Line, Gene Expression Regulation, Humans, Inflammation, Necrosis, Organ Specificity, Protein Binding, Protein Precursors, Signal Transduction, Caspase 1, Mice, Receptors, Interleukin-1 Type II, Interleukin-1alpha, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
